生物
药物开发
中国
临床试验
肿瘤科
药品
内科学
生物信息学
药理学
政治学
医学
法学
作者
Feng Wang,Dan‐Yun Ruan,Rui‐Hua Xu
出处
期刊:Cell
[Elsevier]
日期:2024-03-01
卷期号:187 (7): 1578-1583
被引量:3
标识
DOI:10.1016/j.cell.2024.02.040
摘要
As one of the world's most populous countries, China bears a heavy burden and a broad spectrum of cancers, including unique types, providing a unique environment for drug research and development. In recent years, China has leapt forward in oncology drug development and clinical trials, presenting new opportunities and challenges. As one of the world's most populous countries, China bears a heavy burden and a broad spectrum of cancers, including unique types, providing a unique environment for drug research and development. In recent years, China has leapt forward in oncology drug development and clinical trials, presenting new opportunities and challenges.
科研通智能强力驱动
Strongly Powered by AbleSci AI